Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P1.06 - Epidemiology/Primary Prevention/Tobacco Control and Cessation
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Epidemiology/Primary Prevention/Tobacco Control and Cessation
-
+
P1.06-018 - EGFR Mutations and ALK Gene Rearrangements: Changing Patterns of Molecular Testing in Brazil
09:30 - 09:30 | Presenter: Gilberto Lopes | Author(s): S. Palacio, R. Mudad, E. Prado
- Abstract
Loading...
-
+
P1.07 - Immunology and Immunotherapy
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Immunology and Immunotherapy
-
+
P1.07-024 - ISEND May Predict Clinical Outcomes for Advanced NSCLC Patients on PD-1/PD-L1 Inhibitors but
Not Chemotherapies or Targeted Kinase Inhibitors09:30 - 09:30 | Presenter: Wungki Park | Author(s): D. Kwon, A. Desai, V. Florou, D. Saravia, J. Warsch, Young Kwang Chae, A. Ishkanian, M. Jahanzeb, R. Mudad, Gilberto Lopes
- Abstract
Loading... -
+
P1.07-025 - Correlating ISEND and Tumor Mutation Burden (TMB) with Clinical Outcomes of Advanced Non-Small Cell Lung Cancer (ANSCLC) Patients on Nivolumab
09:30 - 09:30 | Presenter: Wungki Park | Author(s): Gilberto Lopes, D. Kwon, V. Florou, Young Kwang Chae, J. Warsch, A. Ishkanian, M. Jahanzeb, R. Mudad
- Abstract
Loading...
-
+
P1.11 - Patient Advocacy
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Patient Advocacy
-
+
P1.11-001 - Economic Impact of Immune Checkpoint Inhibitor Therapy in Brazil and Strategies to Improve Access
09:30 - 09:30 | Presenter: Pedro Aguiar Jr | Author(s): B. Gutierres, Carmelia Maria Noia Barreto, R.A. De Mello, H. Tadokoro, A. Del Giglio, Gilberto Lopes
- Abstract
Loading...
-
+
P2.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P2.03-006 - How Many Years of Life Have We Lost in Brazil Due to the Lack of Access to Anti-EGFR TKIs in the National Public Health System?
09:30 - 09:30 | Presenter: Pedro Aguiar Jr | Author(s): F. Roitberg, H. Tadokoro, R.A. De Mello, A. Del Giglio, Gilberto Lopes
- Abstract
Loading...
-
+
P2.07 - Immunology and Immunotherapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Immunology and Immunotherapy
-
+
P2.07-037 - Developing a Predictive Clinical Outcome Model for Advanced Non-Small Cell Lung Cancer Patients
Receiving Nivolumab09:30 - 09:30 | Presenter: Wungki Park | Author(s): D. Kwon, D. Saravia, A. Desai, J. Warsch, F. Vargas, M. El Dinali, R. Elias, Y.K. Chae, D.W. Kim, S. Warsch, A. Ishkanian, C. Ikpeazu, R. Mudad, Gilberto Lopes, M. Jahanzeb
- Abstract
Loading... -
+
P2.07-054 - Cost-Effectiveness of Pembrolizumab as First-Line Therapy for Advanced Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Pedro Aguiar Jr | Author(s): M. Georgieva, J.P. Lima, B. Haaland, Gilberto Lopes
- Abstract
Loading... -
+
P2.07-055 - Indirect Comparison between Immune-Checkpoint Inhibitors for 2nd Line Non-Small Cell Lung Cancer – a Network Meta-Analysis
09:30 - 09:30 | Presenter: Pedro Aguiar Jr | Author(s): P. Tan, B. Haaland, Gilberto Lopes
- Abstract
Loading...